# OnCo record moma-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/moma-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "moma-therapeutics" ;
  schema:name "MOMA Therapeutics"@en ;
  schema:description "MOMA Therapeutics makes tablets that block DNA repair machinery that some cancers depend on to survive. One medicine is for tumours with faulty BRCA-type repair, another for tumours with mismatch repair defects."@en ;
  schema:url <https://onco.cc/companies/moma-therapeutics/>, <https://momatx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://momatx.com/>, <https://momatx.com/posts/moma-therapeutics-announces-150-million-series-b-financing/>, <https://momatx.com/posts/moma-therapeutics-provides-corporate-update-and-announces-exclusive-license-agreement-for-selective-parp1-inhibitor/>, <https://clinicaltrials.gov/study/NCT06545942>, <https://clinicaltrials.gov/study/NCT06974110> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/msi-high-colorectal/>, <https://onco.cc/cancers/endometrial-mmr-deficient/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/synthetic-lethality-approaches/>, <https://onco.cc/technologies/parp-inhibitor/> ;
  onco:targets <https://onco.cc/targets/polq/>, <https://onco.cc/targets/wrn/> .